Tsuchiura, Japan

Kenichi Chiba


Average Co-Inventor Count = 15.9

ph-index = 4

Forward Citations = 44(Granted Patents)


Location History:

  • Ibaraki, JP (1993 - 1998)
  • Tsuchiura, JP (1992 - 2012)

Company Filing History:


Years Active: 1992-2012

Loading Chart...
10 patents (USPTO):

Title: Kenichi Chiba: Innovator in Pharmaceutical Compounds

Introduction

Kenichi Chiba is a prominent inventor based in Tsuchiura, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work primarily focuses on macrocyclic compounds that have potential applications in treating various medical disorders.

Latest Patents

One of Kenichi Chiba's latest patents involves macrocyclic compounds useful as pharmaceuticals. This invention provides methods for using compounds with a specific formula in the treatment of inflammatory or autoimmune disorders, as well as disorders related to malignancy or increased angiogenesis. The details of the compounds, including the variables R-R, t, X, Y, Z, and n, are defined within the patent documentation.

Career Highlights

Throughout his career, Kenichi Chiba has worked with notable companies in the pharmaceutical industry, including Eisai Company, Limited and Eisai Inc. His expertise in the development of pharmaceutical compounds has positioned him as a key figure in his field.

Collaborations

Kenichi Chiba has collaborated with several professionals in his industry, including Hiroshi Shirota and Kenzo Muramoto. These collaborations have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Kenichi Chiba's innovative work in the field of pharmaceuticals, particularly with macrocyclic compounds, showcases his dedication to advancing medical treatments. His contributions through patents and collaborations highlight his importance as an inventor in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…